Adv. Keith Shaw is a partner in the Corporate Practice Group at S. Horowitz.
Keith specializes in corporate and commercial transactions, funds and securities regulatory advice, and intellectual property licensing agreements. He advises multinational and domestic companies, investors, and private individuals on international corporate and financial matters, including mergers and acquisitions, venture capital financings, joint ventures, and technology transfer.
In his funds and securities regulatory advisory practice, Keith guides global financial institutions through the regulatory framework of marketing and offering financial products and securities in Israel. He has advised leading institutions including Bank of America, Barclays Bank, Credit Suisse, Deutsche Bank, Goldman Sachs, JP Morgan, UBS, Natixis, and Morgan Stanley. Keith also provides comprehensive counsel to technology transfer organizations, notably Yeda Research and Development Company Ltd., the TTO of the Weizmann Institute of Science.
Known for his exceptional responsiveness and pragmatic approach, Keith has received significant industry recognition.
IAM Patent 1000 2023 ranked him as Recommended for Transactions, noting his “unique insight on how to effectively commercialise IP assets”.
The Legal 500 has praised him as “a strong advocate of his clients’ objectives and needs.”
Hebrew, English
Hebrew, English
vCard